EUVIMEDEUVIMED entdecken
Crossref

Oroxylin-A alleviates hepatic lipid accumulation and apoptosis under hyperlipidemic conditions via AMPK/FGF21 signaling

Wonjun Cho, Sung Woo Choi, Heeseung Oh, A M Abd El-Aty, Ahmet Hacimuftuoglu, Ji Hoon Jeong, Jin-Ho Song, Yong Kyoo Shin, Tae Woo Jung

Biochemical and Biophysical Research Communications · 2023-03 · 648 · 59-65

DOI: 10.1016/j.bbrc.2023.01.090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-03. Verfasst von Wonjun Cho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Ministry of Science, ICT and Future Planning, National Research Foundation of Korea, Chung-Ang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oroxylin-A (OA) is an O-methylated flavone that has been demonstrated to have anti-inflammatory properties in various disease models. However, the roles of OA in hepatic lipid metabolism and the specific molecular mechanisms by which it exerts these effects are not yet fully understood. In the current study, we aimed to investigate the effects of OA on hepatic lipid deposition and apoptosis, which play a pivotal role in the development of nonalcoholic fatty liver disease (NAFLD) in obesity in vitro models. We found that treatment with OA attenuated lipid accumulation, the expression of lipogenesis-associated proteins and apoptosis in palmitate-treated primary mouse hepatocytes. OA treatment suppressed phosphorylated NFκB and IκB expression in as well as TNFα and MCP-1 release from hepatocytes treated with palmitate. Treatment of hepatocytes with OA augmented AMPK phosphorylation and FGF21 expression. siRNA of AMPK or FGF21 abolished the effects of OA on inflammation as well as lipid accumulation and apoptosis in hepatocytes under palmitate treatment conditions. In conclusion, OA improves inflammation through the AMPK/FGF21 pathway, thereby attenuating lipid accumulation and apoptosis in hepatocytes. This study may help identify new targets for developing treatments for NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseMiceAnimalsAMP-Activated Protein KinasesLiverHepatocytesLipid MetabolismInflammationPalmitatesApoptosisMice, Inbred C57BLFlavonoidsFibroblast Growth Factors

Stichwörter der Autor:innen

HepatocyteLipogenesisNAFLDObesityOroxylin-A

Substanzen

AMP-Activated Protein KinasesPalmitates5,7-dihydroxy-6-methoxy-2-phenylchromen-4-oneFlavonoidsfibroblast growth factor 21Fibroblast Growth Factors

Autor:innen und Institutionen

  • Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, 12211, Giza, Egypt; Department of Medical Pharmacology, Medical Faculty, Ataturk University, Erzurum, 25240, Turkey. Electronic address: abde…
  • Department of Medical Pharmacology, Medical Faculty, Ataturk University, Erzurum, 25240, Turkey; Vaccine Development Application and Research Center, Ataturk University, Erzurum, 25240, Turkey.
  • Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea.
  • Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Electronic address: syk@cau.ac.kr.
  • Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Electronic address: twjung@cau.ac.kr.

Förderung

  • Ministry of Science, ICT and Future Planning
  • National Research Foundation of Korea
  • Chung-Ang University

Zitieren

APA

Cho, W., Choi, S. W., Oh, H., Abd El-Aty, A. M., Hacimuftuoglu, A., Jeong, J. H., Song, J. H., Shin, Y. K., & Jung, T. W. (2023). Oroxylin-A alleviates hepatic lipid accumulation and apoptosis under hyperlipidemic conditions via AMPK/FGF21 signaling. Biochemical and Biophysical Research Communications, 648, 59-65. https://doi.org/10.1016/j.bbrc.2023.01.090

Vancouver

Cho W, Choi SW, Oh H, Abd El-Aty AM, Hacimuftuoglu A, Jeong JH, et al. Oroxylin-A alleviates hepatic lipid accumulation and apoptosis under hyperlipidemic conditions via AMPK/FGF21 signaling. Biochemical and Biophysical Research Communications. 2023;648:59-65. doi:10.1016/j.bbrc.2023.01.090

BibTeX
@article{Cho2023,
  author = {Cho, Wonjun and Choi, Sung Woo and Oh, Heeseung and Abd El-Aty, A M and Hacimuftuoglu, Ahmet and Jeong, Ji Hoon and Song, Jin-Ho and Shin, Yong Kyoo and Jung, Tae Woo},
  title = {Oroxylin-A alleviates hepatic lipid accumulation and apoptosis under hyperlipidemic conditions via AMPK/FGF21 signaling},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  volume = {648},
  pages = {59--65},
  doi = {10.1016/j.bbrc.2023.01.090}
}
Kostenlos starten →